GenMark Diagnostics Inc.

GenMark Diagnostics Inc.

GenMark Diagnostics Inc.

Overview
Date Founded

1993

Headquarters

5964 LA PLACE COURT, SUITE 100, CARLSBAD, CA, 92008

Type of Company

Public

Employees (Worldwide)

477

Industries

Medical Products & Equipment
IT Consulting & Services
Hospitals & Patient Services
Medical Support Services

Company Description

GenMark Diagnostics, Inc. is a molecular diagnostics company, which engages in the provision of multiplex molecular diagnostic solutions. Its products include ePlex and XT-8. The company was founded by Jon Faiz Kayyemin 1993 and is headquartered in Carlsbad, CA.

Contact Data
Trying to get in touch with decision makers at GenMark Diagnostics Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

Chief Financial Officer & Principal Accounting Officer

Chief Operating Officer

Secretary, Senior Vice President & General Counsel

Senior Vice President, Corporate Accounts

Senior Vice President, Marketing & Business Development

Senior Vice President, Operations

Senior Account Executive

Vice President & General Manager-Europe, Middle East & Africa

Account Executive

Paths to GenMark Diagnostics Inc.
Potential Connections via
Relationship Science
You
GenMark Diagnostics Inc.
Owners & Shareholders
Details Hidden

Cadian Capital Management manages funds which seek long-term capital appreciation from investments in equity securities of companies in the global telecommunications, media and technology sectors as well as in consumer, healthcare, industrials, financial services and technology and other related sectors. To implement the funds' strategy, Cadian focuses on fundamental stock research and selection through a disciplined upside/downside analysis. They take a value-oriented approach to the sectors in which the funds invest, drawing upon the deep sector expertise of its personnel across geographies and asset classes. The firm focuses on minimizing market and other systemic risks to the funds' portfolios. Cadian seeks conservative net beta exposure through alpha generative long and short positions.Although the funds may hold non-diversified and relatively concentrated portfolios, the primary focus of the funds is to invest in common stocks. Opportunities to enhance capital appreciation are pursued through the use of both long and short positions, margin borrowing, derivatives and other instruments or securities. Depending on market conditions and available investment opportunities, the funds' portfolios may be concentrated in some or all of the sectors listed above or, alternatively, the funds may focus on investment opportunities in other unrelated sectors. Cadian may also make use of various hedging techniques that might include, but are not limited to, currency hedging, short sales, and the writing of stock options and options on stock market indices (and/or investing directly in these indices).

Details Hidden

Casdin Capital focuses on investments in disruptive businesses and is positioned to capitalize off an underappreciated, disruptive technology shift currently unfolding in the life sciences and healthcare industry. They consider investment opportunities that span the entire healthcare continuum and into sectors such as agriculture, industrial manufacturing and traditional information technology.

Details Hidden

Millrace Asset Group manages the Millrace Fund, a long/short US small-cap equity portfolio

Recent Transactions
Details Hidden

GenMark Diagnostics Inc. issued USD Common Stock

Details Hidden

GenMark Diagnostics Inc. issued Common Stock

Details Hidden

GenMark Diagnostics Inc. issued Common Stock

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Underwriter

Advised onGenMark Diagnostics Inc. issued USD Common Stock

Auditor

Advised onGenMark Diagnostics Inc. issued Common Stock

Underwriter

Advised onGenMark Diagnostics Inc. issued Common Stock

Associate

Advised onGenMark Diagnostics Inc. issued USD Common Stock

Managing Director

Advised onGenMark Diagnostics Inc. issued USD Common Stock

Underwriter

Advised onGenMark Diagnostics Inc. issued USD Common Stock

Advisors & Consultants
Legal Advisor

Partner at Gunderson Dettmer Stough Villeneuve Franklin & Hachigian LLP

Advisor

Chief Financial Officer at Biological Dynamics, Inc.

Clients

LabCorp provides leading-edge medical laboratory tests and services through a national network of primary clinical laboratories and specialized Centers of Excellence. Recognized for our innovation, quality, and customer convenience, LabCorp delivers timely, accurate results for improved patient care. With scientific expertise in esoteric testing, genomics, and clinical and anatomic pathology, LabCorp performs more than 1 million tests on more than 370,000 specimens each day. LabCorp is a pioneer in applying advances in medicine and science to laboratory testing, with more than 35 years of experience in serving physicians and their patients. LabCorp operates a sophisticated laboratory network, with corporate headquarters in Burlington, NC, and more than 30,000 employees nationwide. Our 220,000 clients include physician offices, hospitals, managed care organizations, and biotechnology and pharmaceutical companies. Laboratory Corporation of America Holdings is listed on the New York Stock Exchange (NYSE) under ticker symbol LH

Key Stats and Financials As of 2018
Market Capitalization
$431M
Total Enterprise Value
$261M
Earnings Per Share
$-0.91
Revenue
$70.8M
EBITDAMargin
-57.5%
Net Profit
$-50.5M
EBITDA
$-40.7M
Total Equity
$33.5M
Total Debt
$36M
Enterprise Value Sales
3.69x
TEVNet Income
-5.18x
Debt TEV
0.14x
Three Year Compounded Annual Growth Rate Of Revenue
21.54%
Five Year Compounded Annual Growth Rate Of Revenue
20.89%
Political Donations
$1,000
2011
Suppliers
Illumina, Inc. Computer Software | SAN DIEGO, CA

Illumina, Inc. engages in the development and manufacture of integrated systems for the analysis of genetic variation and function. It operates through the Core Illumina and Consolidated Variable Interest Entity segments (VIE). The Core Illumina segments serve customers in the research, clinical and applied markets, and enable the adoption of genomic solutions. The Consolidated VIE segment includes activities of GRAIL and Helix. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

California Institute of Technology Schools & Student Services | PASADENA , CA

California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA.

Plexus Corp. Automobiles | Neenah, WI

Plexus Corp. engages in the provision of electronic manufacturing services. The firm partners with companies to transform concepts into branded products and deliver them to the market. It has partnerships with customers in the healthcare and life sciences; industrial and commercial; communications; and aerospace and defense market sectors. The company operates through the following geographical segments: Americas (AMER); Europe, Middle East, and Africa (EMEA); and Asia-Pacific (APAC). Plexus was founded by Peter Strandwitz, Shirani Ramin and John L. Nussbaum in 1979 and is headquartered in Neenah, WI.

Competitors
Danaher Corporation Industrial Machinery & Manufacturing - Washington, DC

Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial and commercial products and services. It operates through the following five segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines. The Diagnostics segment comprises of analytical instruments, reagents, consumables, software, and services that hospitals, physician's offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Dental segment develops products and services that are used to diagnose, treat and prevent disease and ailments of the teeth, gums, and supporting bones; as well as to improve the aesthetics of the human smile. The Environmental & Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1969 and is headquartered in Washington, DC.

Laboratory Corporation of America Holdings Medical Support Services - Burlington, NC

LabCorp provides leading-edge medical laboratory tests and services through a national network of primary clinical laboratories and specialized Centers of Excellence. Recognized for our innovation, quality, and customer convenience, LabCorp delivers timely, accurate results for improved patient care. With scientific expertise in esoteric testing, genomics, and clinical and anatomic pathology, LabCorp performs more than 1 million tests on more than 370,000 specimens each day. LabCorp is a pioneer in applying advances in medicine and science to laboratory testing, with more than 35 years of experience in serving physicians and their patients. LabCorp operates a sophisticated laboratory network, with corporate headquarters in Burlington, NC, and more than 30,000 employees nationwide. Our 220,000 clients include physician offices, hospitals, managed care organizations, and biotechnology and pharmaceutical companies. Laboratory Corporation of America Holdings is listed on the New York Stock Exchange (NYSE) under ticker symbol LH

Abbott Laboratories Pharmaceuticals - Abbott Park, Illinois

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by GenMark Diagnostics Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of GenMark Diagnostics Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and GenMark Diagnostics Inc..